Debt-to-equity of ALNYLAM PHARMACEUTICALS, INC. from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ALNYLAM PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • ALNYLAM PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 1239%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ALNYLAM PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 1239% +14585% 31 Dec 2025
Q3 2025 2579% +6544% 30 Sep 2025
Q2 2025 3601% +6247% 30 Jun 2025
Q1 2025 7770% +9339% 31 Mar 2025
Q4 2024 -13346% -11874% -806% 31 Dec 2024
Q3 2024 -3965% -2434% -159% 30 Sep 2024
Q2 2024 -2646% -993% -60% 30 Jun 2024
Q1 2024 -1569% +2997% +66% 31 Mar 2024
Q4 2023 -1472% -5313% -138% 31 Dec 2023
Q3 2023 -1530% -2700% -231% 30 Sep 2023
Q2 2023 -1653% -2276% -366% 30 Jun 2023
Q1 2023 -4566% -5007% -1135% 31 Mar 2023
Q4 2022 3841% +3496% +1015% 31 Dec 2022
Q3 2022 1170% +886% +312% 30 Sep 2022
Q2 2022 622% +386% +164% 30 Jun 2022
Q1 2022 441% +248% +129% 31 Mar 2022
Q4 2021 344% +196% +132% 31 Dec 2021
Q3 2021 284% +174% +158% 30 Sep 2021
Q2 2021 236% +153% +185% 30 Jun 2021
Q1 2021 193% +131% +214% 31 Mar 2021
Q4 2020 148% +96% +184% 31 Dec 2020
Q3 2020 110% +68% +160% 30 Sep 2020
Q2 2020 83% +52% +165% 30 Jun 2020
Q1 2020 61% +43% +230% 31 Mar 2020
Q4 2019 52% +39% +298% 31 Dec 2019
Q3 2019 42% +31% +268% 30 Sep 2019
Q2 2019 31% +17% +124% 30 Jun 2019
Q1 2019 19% +0.93% +5.3% 31 Mar 2019
Q4 2018 13% -11% -45% 31 Dec 2018
Q3 2018 12% -20% -64% 30 Sep 2018
Q2 2018 14% -18% -57% 30 Jun 2018
Q1 2018 18% -14% -44% 31 Mar 2018
Q4 2017 24% -1% -4.1% 31 Dec 2017
Q3 2017 32% +14% +76% 30 Sep 2017
Q2 2017 32% +19% +143% 30 Jun 2017
Q1 2017 32% +22% +238% 31 Mar 2017
Q4 2016 25% +16% +179% 31 Dec 2016
Q3 2016 18% +8.3% +83% 30 Sep 2016
Q2 2016 13% +3.2% +32% 30 Jun 2016
Q1 2016 9.4% -1.1% -10% 31 Mar 2016
Q4 2015 8.9% -2.9% -24% 31 Dec 2015
Q3 2015 9.9% -4.6% -32% 30 Sep 2015
Q2 2015 10% -11% -52% 30 Jun 2015
Q1 2015 10% -21% -67% 31 Mar 2015
Q4 2014 12% -40% -77% 31 Dec 2014
Q3 2014 15% -44% -75% 30 Sep 2014
Q2 2014 21% -45% -68% 30 Jun 2014
Q1 2014 32% -41% -56% 31 Mar 2014
Q4 2013 52% -30% -37% 31 Dec 2013
Q3 2013 59% -27% -31% 30 Sep 2013
Q2 2013 66% -32% -33% 30 Jun 2013
Q1 2013 73% -47% -39% 31 Mar 2013
Q4 2012 82% -65% -44% 31 Dec 2012
Q3 2012 86% -63% -43% 30 Sep 2012
Q2 2012 98% -54% -36% 30 Jun 2012
Q1 2012 120% -37% -24% 31 Mar 2012
Q4 2011 147% 31 Dec 2011
Q3 2011 149% 30 Sep 2011
Q2 2011 152% 30 Jun 2011
Q1 2011 156% 31 Mar 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.